John Pagel, M.D., Ph.D., Actinium Advisory Board Member, to Discuss Bone Marrow Transplant as a Treatment Option for Patients With AML Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) ("Actinium" or ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A hematologist in Italy shared his personal experience addressing the intersection of COVID-19 and ...
Bionano announced a significant study published in the American Journal of Hematology demonstrating the utility of optical genome mapping (OGM) in detecting structural variants associated with ...
NEW YORK, NY--(Marketwired - June 15, 2016) - Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) Webinar to Be Held on Friday, June 17, 2016 Featuring Thought Leaders in the Field of AML John Pagel, M.D.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results